ReP USP - Resultado da busca

Trabalho de evento-resumo
Identification of active small molecules targeting the endopeptidase RipA from Mycobacterium tuberculosis (2025)
Silva, Catharina dos Santos ; Rodrigues, Vinícius Lopes Tarouquella; Libreros-Zunigã, Gerardo Andrés; Rossini, Nicolas de Oliveira ; Guterrez, Kevim Bordignon; Barroso, Vinícius de Morais ; Mesquita, Nathalya Cristina de Moraes Roso ; Tinoco, Luzineide Wanderley; Sforça, Maurício Luis; Guimarães, Ana Marcia de Sá ; Ishida, Kelly ; Emery, Flavio da Silva ; Dias, Marcio Vinicius Bertacine
Source: Annals. Conference titles: Brazilian Symposium on Medicinal Chemistry - BrazMedChem. Unidades: ICB, FCFRP, FMVZ, IFSC
Subjects: TUBERCULOSE, RESSONÂNCIA MAGNÉTICA NUCLEAR, PESQUISA CIENTÍFICA, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Catharina dos Santos et al. Identification of active small molecules targeting the endopeptidase RipA from Mycobacterium tuberculosis. 2025, Anais.. Rio de Janeiro: Universidade Federal do Rio de Janeiro - UFRJ, 2025. Disponível em: https://repositorio.usp.br/directbitstream/cfa531b1-fb7d-46da-821e-ef6370ef75c3/3290241.pdf. Acesso em: 22 abr. 2026.
APA
Silva, C. dos S., Rodrigues, V. L. T., Libreros-Zunigã, G. A., Rossini, N. de O., Guterrez, K. B., Barroso, V. de M., et al. (2025). Identification of active small molecules targeting the endopeptidase RipA from Mycobacterium tuberculosis. In Annals. Rio de Janeiro: Universidade Federal do Rio de Janeiro - UFRJ. Recuperado de https://repositorio.usp.br/directbitstream/cfa531b1-fb7d-46da-821e-ef6370ef75c3/3290241.pdf
NLM
Silva C dos S, Rodrigues VLT, Libreros-Zunigã GA, Rossini N de O, Guterrez KB, Barroso V de M, Mesquita NC de MR, Tinoco LW, Sforça ML, Guimarães AM de S, Ishida K, Emery F da S, Dias MVB. Identification of active small molecules targeting the endopeptidase RipA from Mycobacterium tuberculosis [Internet]. Annals. 2025 ;[citado 2026 abr. 22 ] Available from: https://repositorio.usp.br/directbitstream/cfa531b1-fb7d-46da-821e-ef6370ef75c3/3290241.pdf
Vancouver
Silva C dos S, Rodrigues VLT, Libreros-Zunigã GA, Rossini N de O, Guterrez KB, Barroso V de M, Mesquita NC de MR, Tinoco LW, Sforça ML, Guimarães AM de S, Ishida K, Emery F da S, Dias MVB. Identification of active small molecules targeting the endopeptidase RipA from Mycobacterium tuberculosis [Internet]. Annals. 2025 ;[citado 2026 abr. 22 ] Available from: https://repositorio.usp.br/directbitstream/cfa531b1-fb7d-46da-821e-ef6370ef75c3/3290241.pdf
Artigo de periodico
Advances and challenges in molecular docking applied to neglected tropical diseases (2025)
Angelo, Rafaela Molina de ; Nascimento, Lucas Alex; Encide, João Pedro Portilho; Silva, Henrique Borges da ; Lago, João Henrique Ghilardi ; Emery, Flavio da Silva ; Honorio, Kathia Maria
Source: Current Medicinal Chemistry. Unidades: FCFRP, EACH
Assunto: DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANGELO, Rafaela Molina de et al. Advances and challenges in molecular docking applied to neglected tropical diseases. Current Medicinal Chemistry, n. Ja 2025, p. 01-21, 2025Tradução . . Disponível em: http://dx.doi.org/10.2174/0109298673327352240930040103. Acesso em: 22 abr. 2026.
APA
Angelo, R. M. de, Nascimento, L. A., Encide, J. P. P., Silva, H. B. da, Lago, J. H. G., Emery, F. da S., & Honorio, K. M. (2025). Advances and challenges in molecular docking applied to neglected tropical diseases. Current Medicinal Chemistry, ( Ja 2025), 01-21. doi:10.2174/0109298673327352240930040103
NLM
Angelo RM de, Nascimento LA, Encide JPP, Silva HB da, Lago JHG, Emery F da S, Honorio KM. Advances and challenges in molecular docking applied to neglected tropical diseases [Internet]. Current Medicinal Chemistry. 2025 ;( Ja 2025): 01-21.[citado 2026 abr. 22 ] Available from: http://dx.doi.org/10.2174/0109298673327352240930040103
Vancouver
Angelo RM de, Nascimento LA, Encide JPP, Silva HB da, Lago JHG, Emery F da S, Honorio KM. Advances and challenges in molecular docking applied to neglected tropical diseases [Internet]. Current Medicinal Chemistry. 2025 ;( Ja 2025): 01-21.[citado 2026 abr. 22 ] Available from: http://dx.doi.org/10.2174/0109298673327352240930040103
Curadoria
Brazilian Symposium on Medicinal Chemistry -BrazMedChem, 12 (2025)
Oliva, Glaucius (cur) ; Guido, Rafael Victorio Carvalho (cur) ; Leitão, Andrei (cur) ; Emery, Flavio da Silva (cur) ; Trossini, Gustavo Henrique Goulart (cur) ; Nonato, Maria Cristina (cur) ; Valli, Marilia (cur)
Unidades: IFSC, IQSC, FCFRP, FCF
Subjects: QUÍMICA MÉDICA, EVENTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Brazilian Symposium on Medicinal Chemistry -BrazMedChem, 12. . Rio de Janeiro: Universidade Federal do Rio de Janeiro - UFRJ. Disponível em: https://repositorio.usp.br/directbitstream/f55ceb5a-e6d4-4d58-b6fb-432e83cf9927/3277219.pdf. Acesso em: 22 abr. 2026. , 2025
APA
Brazilian Symposium on Medicinal Chemistry -BrazMedChem, 12. (2025). Brazilian Symposium on Medicinal Chemistry -BrazMedChem, 12. Rio de Janeiro: Universidade Federal do Rio de Janeiro - UFRJ. Recuperado de https://repositorio.usp.br/directbitstream/f55ceb5a-e6d4-4d58-b6fb-432e83cf9927/3277219.pdf
NLM
Brazilian Symposium on Medicinal Chemistry -BrazMedChem, 12 [Internet]. 2025 ;[citado 2026 abr. 22 ] Available from: https://repositorio.usp.br/directbitstream/f55ceb5a-e6d4-4d58-b6fb-432e83cf9927/3277219.pdf
Vancouver
Brazilian Symposium on Medicinal Chemistry -BrazMedChem, 12 [Internet]. 2025 ;[citado 2026 abr. 22 ] Available from: https://repositorio.usp.br/directbitstream/f55ceb5a-e6d4-4d58-b6fb-432e83cf9927/3277219.pdf
Trabalho de evento-resumo
Brazilian Symposium on Medicinal Chemistry - BrazMedChem (2025)
Leitão, Andrei (cur) ; Emery, Flavio da Silva (cur) ; Trossini, Gustavo Henrique Goulart (cur) ; Nonato, Maria Cristina (cur) ; Valli, Marilia (cur)
Source: Annals. Conference titles: Brazilian Symposium on Medicinal Chemistry - BrazMedChem. Unidades: IQSC, FCFRP, FCF
Assunto: QUÍMICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Brazilian Symposium on Medicinal Chemistry - BrazMedChem. 2025, Anais.. Rio de Janeiro: Universidade Federal do Rio de Janeiro - UFRJ, 2025. Disponível em: https://brazmedchem.org/annals-xii-brazmedchem/. Acesso em: 22 abr. 2026.
APA
Brazilian Symposium on Medicinal Chemistry - BrazMedChem. (2025). Brazilian Symposium on Medicinal Chemistry - BrazMedChem. In Annals. Rio de Janeiro: Universidade Federal do Rio de Janeiro - UFRJ. Recuperado de https://brazmedchem.org/annals-xii-brazmedchem/
NLM
Brazilian Symposium on Medicinal Chemistry - BrazMedChem [Internet]. Annals. 2025 ;[citado 2026 abr. 22 ] Available from: https://brazmedchem.org/annals-xii-brazmedchem/
Vancouver
Brazilian Symposium on Medicinal Chemistry - BrazMedChem [Internet]. Annals. 2025 ;[citado 2026 abr. 22 ] Available from: https://brazmedchem.org/annals-xii-brazmedchem/
Trabalho de evento-resumo
Using a fragment-based approach against a potential novel drug target in Mycobacterium tuberculosis (2025)
Silva, Catharina dos Santos ; Rodrigues, Vinícius Lopes Tarouquella; Libreros-Zunigã, Gerardo Andrés; Rossini, Nicolas de Oliveira ; Guterrez, Kevim; Barroso, Vinícius de Morais ; Mesquita, Nathalya Cristina de Moraes Roso ; Tinoco, Luzineide; Sforça, Maurício Luis; Guimarães, Ana Marcia de Sá ; Ishida, Kelly ; Emery, Flavio da Silva ; Dias, Marcio Vinicius Bertacine
Source: Livro de Resumos. Conference titles: Annual Meeting of the Brazilian Society for Biochemistry and Molecular Biology - SBBq. Unidades: ICB, FCFRP, IFSC
Subjects: TUBERCULOSE, PLANEJAMENTO DE FÁRMACOS, RESSONÂNCIA MAGNÉTICA NUCLEAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Catharina dos Santos et al. Using a fragment-based approach against a potential novel drug target in Mycobacterium tuberculosis. 2025, Anais.. São Paulo: Sociedade Brasileira de Bioquímica e Biologia Molecular - SBBq, 2025. Disponível em: https://www2.sbbq.org.br/reuniao/2025/images/resumos.pdf. Acesso em: 22 abr. 2026.
APA
Silva, C. dos S., Rodrigues, V. L. T., Libreros-Zunigã, G. A., Rossini, N. de O., Guterrez, K., Barroso, V. de M., et al. (2025). Using a fragment-based approach against a potential novel drug target in Mycobacterium tuberculosis. In Livro de Resumos. São Paulo: Sociedade Brasileira de Bioquímica e Biologia Molecular - SBBq. Recuperado de https://www2.sbbq.org.br/reuniao/2025/images/resumos.pdf
NLM
Silva C dos S, Rodrigues VLT, Libreros-Zunigã GA, Rossini N de O, Guterrez K, Barroso V de M, Mesquita NC de MR, Tinoco L, Sforça ML, Guimarães AM de S, Ishida K, Emery F da S, Dias MVB. Using a fragment-based approach against a potential novel drug target in Mycobacterium tuberculosis [Internet]. Livro de Resumos. 2025 ;[citado 2026 abr. 22 ] Available from: https://www2.sbbq.org.br/reuniao/2025/images/resumos.pdf
Vancouver
Silva C dos S, Rodrigues VLT, Libreros-Zunigã GA, Rossini N de O, Guterrez K, Barroso V de M, Mesquita NC de MR, Tinoco L, Sforça ML, Guimarães AM de S, Ishida K, Emery F da S, Dias MVB. Using a fragment-based approach against a potential novel drug target in Mycobacterium tuberculosis [Internet]. Livro de Resumos. 2025 ;[citado 2026 abr. 22 ] Available from: https://www2.sbbq.org.br/reuniao/2025/images/resumos.pdf
Artigo de periodico
Fragment screening reveals novel scaffolds against sirtuin-2-related Protein 1 from Trypanosoma brucei (2025)
Gomes, Renan Augusto; Polêto, Marcelo Depólo; Verli, Hugo ; Almeida, Vitor Medeiros ; Marana, Sandro Roberto ; Bender, Andreas ; Godoi, Bruna Fleck; Rodrigues, Vinícius T. L; Emery, Flavio da Silva ; Trossini, Gustavo Henrique Goulart
Source: ACS Omega. Unidades: IQ, FCFRP, FCF
Subjects: TRYPANOSOMA, LIGANTES, PEPTÍDEOS, PROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Renan Augusto et al. Fragment screening reveals novel scaffolds against sirtuin-2-related Protein 1 from Trypanosoma brucei. ACS Omega, v. 10, n. 4, p. 3808–3819, 2025Tradução . . Disponível em: https://dx.doi.org/10.1021/acsomega.4c09231. Acesso em: 22 abr. 2026.
APA
Gomes, R. A., Polêto, M. D., Verli, H., Almeida, V. M., Marana, S. R., Bender, A., et al. (2025). Fragment screening reveals novel scaffolds against sirtuin-2-related Protein 1 from Trypanosoma brucei. ACS Omega, 10( 4), 3808–3819. doi:10.1021/acsomega.4c09231
NLM
Gomes RA, Polêto MD, Verli H, Almeida VM, Marana SR, Bender A, Godoi BF, Rodrigues VTL, Emery F da S, Trossini GHG. Fragment screening reveals novel scaffolds against sirtuin-2-related Protein 1 from Trypanosoma brucei [Internet]. ACS Omega. 2025 ; 10( 4): 3808–3819.[citado 2026 abr. 22 ] Available from: https://dx.doi.org/10.1021/acsomega.4c09231
Vancouver
Gomes RA, Polêto MD, Verli H, Almeida VM, Marana SR, Bender A, Godoi BF, Rodrigues VTL, Emery F da S, Trossini GHG. Fragment screening reveals novel scaffolds against sirtuin-2-related Protein 1 from Trypanosoma brucei [Internet]. ACS Omega. 2025 ; 10( 4): 3808–3819.[citado 2026 abr. 22 ] Available from: https://dx.doi.org/10.1021/acsomega.4c09231
Artigo de periodico
Unveiling the antiviral capabilities of targeting human dihydroorotate dehydrogenase against SARS-CoV-2 (2024)
Purificação, Aline Dias da ; Silva-Mendonça, Sabrina ; Cruz, Luiza V.; Sacramento, Carolina Q.; Temerozo, Jairo R.; Fintelman-Rodrigues, Natalia; Freitas, Caroline Souza de; Godoi, Bruna Fleck ; Vaidergorn, Miguel Menezes ; Leite, Juliana Almeida; Salazar-Alvarez, Luis Carlos ; Freitas, Murillo V.; Silvac, Meryck F. B.; Martin, Bianca Aparecida ; Lopez, Renata Fonseca Vianna ; Neves, Bruno J.; Costa, Fabio T. M.; Souza, Thiago M. L.; Emery, Flavio da Silva ; Andrade, Carolina Horta ; Nonato, Maria Cristina
Source: ACS Omega. Unidades: FCFRP, ICMC, FMRP
Subjects: COVID-19, ANTIVIRAIS, SURTOS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PURIFICAÇÃO, Aline Dias da et al. Unveiling the antiviral capabilities of targeting human dihydroorotate dehydrogenase against SARS-CoV-2. ACS Omega, v. 9, n. 10, p. 11418-11430, 2024Tradução . . Disponível em: https://doi.org/10.1021/acsomega.3c07845. Acesso em: 22 abr. 2026.
APA
Purificação, A. D. da, Silva-Mendonça, S., Cruz, L. V., Sacramento, C. Q., Temerozo, J. R., Fintelman-Rodrigues, N., et al. (2024). Unveiling the antiviral capabilities of targeting human dihydroorotate dehydrogenase against SARS-CoV-2. ACS Omega, 9( 10), 11418-11430. doi:10.1021/acsomega.3c07845
NLM
Purificação AD da, Silva-Mendonça S, Cruz LV, Sacramento CQ, Temerozo JR, Fintelman-Rodrigues N, Freitas CS de, Godoi BF, Vaidergorn MM, Leite JA, Salazar-Alvarez LC, Freitas MV, Silvac MFB, Martin BA, Lopez RFV, Neves BJ, Costa FTM, Souza TML, Emery F da S, Andrade CH, Nonato MC. Unveiling the antiviral capabilities of targeting human dihydroorotate dehydrogenase against SARS-CoV-2 [Internet]. ACS Omega. 2024 ; 9( 10): 11418-11430.[citado 2026 abr. 22 ] Available from: https://doi.org/10.1021/acsomega.3c07845
Vancouver
Purificação AD da, Silva-Mendonça S, Cruz LV, Sacramento CQ, Temerozo JR, Fintelman-Rodrigues N, Freitas CS de, Godoi BF, Vaidergorn MM, Leite JA, Salazar-Alvarez LC, Freitas MV, Silvac MFB, Martin BA, Lopez RFV, Neves BJ, Costa FTM, Souza TML, Emery F da S, Andrade CH, Nonato MC. Unveiling the antiviral capabilities of targeting human dihydroorotate dehydrogenase against SARS-CoV-2 [Internet]. ACS Omega. 2024 ; 9( 10): 11418-11430.[citado 2026 abr. 22 ] Available from: https://doi.org/10.1021/acsomega.3c07845
Artigo de periodico
Introducing CRAFT: the Center for Research and Advancement in Fragments and molecular Targets (2024)
Andrade, Carolina Horta; Nonato, Maria Cristina ; Emery, Flavio da Silva
Source: ACS Medicinal Chemistry Letters. Unidade: FCFRP
Subjects: FÁRMACOS, INTELIGÊNCIA ARTIFICIAL, DOENÇAS NEGLIGENCIADAS, INSTITUTOS DE PESQUISA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, Carolina Horta e NONATO, Maria Cristina e EMERY, Flavio da Silva. Introducing CRAFT: the Center for Research and Advancement in Fragments and molecular Targets. ACS Medicinal Chemistry Letters, v. 15, n. 8, p. 1174-1177, 2024Tradução . . Disponível em: https://doi.org/10.1021/acsmedchemlett.4c00296. Acesso em: 22 abr. 2026.
APA
Andrade, C. H., Nonato, M. C., & Emery, F. da S. (2024). Introducing CRAFT: the Center for Research and Advancement in Fragments and molecular Targets. ACS Medicinal Chemistry Letters, 15( 8), 1174-1177. doi:10.1021/acsmedchemlett.4c00296
NLM
Andrade CH, Nonato MC, Emery F da S. Introducing CRAFT: the Center for Research and Advancement in Fragments and molecular Targets [Internet]. ACS Medicinal Chemistry Letters. 2024 ; 15( 8): 1174-1177.[citado 2026 abr. 22 ] Available from: https://doi.org/10.1021/acsmedchemlett.4c00296
Vancouver
Andrade CH, Nonato MC, Emery F da S. Introducing CRAFT: the Center for Research and Advancement in Fragments and molecular Targets [Internet]. ACS Medicinal Chemistry Letters. 2024 ; 15( 8): 1174-1177.[citado 2026 abr. 22 ] Available from: https://doi.org/10.1021/acsmedchemlett.4c00296
Artigo de periodico
Electrostimulable polymeric films with hyaluronic acid and lipid nanoparticles for simultaneous topical delivery of macromolecules and lipophilic drugs (2024)
Martin, Bianca Aparecida ; Dalmolin, Luciana Facco ; Lemos, Camila Nunes; Vaidergorn, Miguel de Menezes ; Emery, Flavio da Silva ; Vargas-Rechia, Carem Gledes ; Ramos, Ana Paula ; Lopez, Renata Fonseca Vianna
Source: Drug Delivery and Translational Research. Unidades: FCFRP, FFCLRP
Subjects: NANOPARTÍCULAS, LIPÍDEOS, ÁCIDOS, ESTIMULAÇÃO ELÉTRICA, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTIN, Bianca Aparecida et al. Electrostimulable polymeric films with hyaluronic acid and lipid nanoparticles for simultaneous topical delivery of macromolecules and lipophilic drugs. Drug Delivery and Translational Research, v. 14, n. 9, p. 2499-2519, 2024Tradução . . Disponível em: https://doi.org/10.1007/s13346-024-01526-9. Acesso em: 22 abr. 2026.
APA
Martin, B. A., Dalmolin, L. F., Lemos, C. N., Vaidergorn, M. de M., Emery, F. da S., Vargas-Rechia, C. G., et al. (2024). Electrostimulable polymeric films with hyaluronic acid and lipid nanoparticles for simultaneous topical delivery of macromolecules and lipophilic drugs. Drug Delivery and Translational Research, 14( 9), 2499-2519. doi:10.1007/s13346-024-01526-9
NLM
Martin BA, Dalmolin LF, Lemos CN, Vaidergorn M de M, Emery F da S, Vargas-Rechia CG, Ramos AP, Lopez RFV. Electrostimulable polymeric films with hyaluronic acid and lipid nanoparticles for simultaneous topical delivery of macromolecules and lipophilic drugs [Internet]. Drug Delivery and Translational Research. 2024 ; 14( 9): 2499-2519.[citado 2026 abr. 22 ] Available from: https://doi.org/10.1007/s13346-024-01526-9
Vancouver
Martin BA, Dalmolin LF, Lemos CN, Vaidergorn M de M, Emery F da S, Vargas-Rechia CG, Ramos AP, Lopez RFV. Electrostimulable polymeric films with hyaluronic acid and lipid nanoparticles for simultaneous topical delivery of macromolecules and lipophilic drugs [Internet]. Drug Delivery and Translational Research. 2024 ; 14( 9): 2499-2519.[citado 2026 abr. 22 ] Available from: https://doi.org/10.1007/s13346-024-01526-9
Artigo de periodico
SETDB1 as a cancer target: challenges and perspectives in drug design (2024)
Hassanie, Haifa ; Penteado, André Berndt ; Almeida, Larissa Costa de ; Calil, Raisa Ludmila; Emery, Flavio da Silva ; Costa-Lotufo, Letícia Veras ; Trossini, Gustavo Henrique Goulart
Source: RSC Medicinal Chemistry. Unidades: FCFRP, ICB, FCF
Subjects: NEOPLASIAS, MEDICAMENTO, GENOMAS, CÉLULAS CULTIVADAS DE TUMOR, EPIGÊNESE GENÉTICA, CROMATINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HASSANIE, Haifa et al. SETDB1 as a cancer target: challenges and perspectives in drug design. RSC Medicinal Chemistry, v. 15, n. 5, p. 1424-1451, 2024Tradução . . Disponível em: https://dx.doi.org/10.1039/D3MD00366C. Acesso em: 22 abr. 2026.
APA
Hassanie, H., Penteado, A. B., Almeida, L. C. de, Calil, R. L., Emery, F. da S., Costa-Lotufo, L. V., & Trossini, G. H. G. (2024). SETDB1 as a cancer target: challenges and perspectives in drug design. RSC Medicinal Chemistry, 15( 5), 1424-1451. doi:10.1039/D3MD00366C
NLM
Hassanie H, Penteado AB, Almeida LC de, Calil RL, Emery F da S, Costa-Lotufo LV, Trossini GHG. SETDB1 as a cancer target: challenges and perspectives in drug design [Internet]. RSC Medicinal Chemistry. 2024 ; 15( 5): 1424-1451.[citado 2026 abr. 22 ] Available from: https://dx.doi.org/10.1039/D3MD00366C
Vancouver
Hassanie H, Penteado AB, Almeida LC de, Calil RL, Emery F da S, Costa-Lotufo LV, Trossini GHG. SETDB1 as a cancer target: challenges and perspectives in drug design [Internet]. RSC Medicinal Chemistry. 2024 ; 15( 5): 1424-1451.[citado 2026 abr. 22 ] Available from: https://dx.doi.org/10.1039/D3MD00366C
Curadoria
Brazilian Symposium on Medicinal Chemistry - BrazMedChem, 11 (2023)
Andricopulo, Adriano Defini (cur) ; Trossini, Gustavo Henrique Goulart (cur) ; Nonato, Maria Cristina (cur) ; Nascimento, Alessandro Silva (cur) ; Emery, Flavio da Silva (cur) ; Dias, Marcio Vinicius Bertacine (cur) ; Parise Filho, Roberto (cur)
Unidades: IFSC, FCF, FCFRP, ICB
Subjects: CRISTALOGRAFIA, QUÍMICA MÉDICA, PESQUISA CIENTÍFICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Brazilian Symposium on Medicinal Chemistry - BrazMedChem, 11. . Salvador: Universidade Federal da Bahia - UFBA. . Acesso em: 22 abr. 2026. , 2023
APA
Brazilian Symposium on Medicinal Chemistry - BrazMedChem, 11. (2023). Brazilian Symposium on Medicinal Chemistry - BrazMedChem, 11. Salvador: Universidade Federal da Bahia - UFBA.
NLM
Brazilian Symposium on Medicinal Chemistry - BrazMedChem, 11. 2023 ;[citado 2026 abr. 22 ]
Vancouver
Brazilian Symposium on Medicinal Chemistry - BrazMedChem, 11. 2023 ;[citado 2026 abr. 22 ]
Artigo de periodico
Human sirtuin 2 inhibitors, their mechanisms and binding modes (2023)
Penteado, André Berndt ; Hassanie, Haifa ; Gomes, Renan Augusto ; Emery, Flavio da Silva ; Trossini, Gustavo Henrique Goulart
Source: Future Medicinal Chemistry. Unidades: FCFRP, FCF
Subjects: METABOLISMO, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PENTEADO, André Berndt et al. Human sirtuin 2 inhibitors, their mechanisms and binding modes. Future Medicinal Chemistry, v. 15, n. 3, p. 291-311, 2023Tradução . . Disponível em: https://doi.org/10.4155/fmc-2022-0253. Acesso em: 22 abr. 2026.
APA
Penteado, A. B., Hassanie, H., Gomes, R. A., Emery, F. da S., & Trossini, G. H. G. (2023). Human sirtuin 2 inhibitors, their mechanisms and binding modes. Future Medicinal Chemistry, 15( 3), 291-311. doi:10.4155/fmc-2022-0253
NLM
Penteado AB, Hassanie H, Gomes RA, Emery F da S, Trossini GHG. Human sirtuin 2 inhibitors, their mechanisms and binding modes [Internet]. Future Medicinal Chemistry. 2023 ; 15( 3): 291-311.[citado 2026 abr. 22 ] Available from: https://doi.org/10.4155/fmc-2022-0253
Vancouver
Penteado AB, Hassanie H, Gomes RA, Emery F da S, Trossini GHG. Human sirtuin 2 inhibitors, their mechanisms and binding modes [Internet]. Future Medicinal Chemistry. 2023 ; 15( 3): 291-311.[citado 2026 abr. 22 ] Available from: https://doi.org/10.4155/fmc-2022-0253
Artigo de periodico
Synthesis and vectorial functionalisation of pyrazolo[3,4-c]pyridines (2023)
Bedwell, Elizabeth V.; Emery, Flavio da Silva ; Clososki, Giuliano Cesar ; Steel, Patrick G.
Source: RSC Advances. Unidade: FCFRP
Subjects: FÁRMACOS, ÁTOMOS, ELETRÓLITOS, QUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BEDWELL, Elizabeth V. et al. Synthesis and vectorial functionalisation of pyrazolo[3,4-c]pyridines. RSC Advances, v. 13, n. 49, p. 34391-34399, 2023Tradução . . Disponível em: https://doi.org/10.1039/D3RA07458G. Acesso em: 22 abr. 2026.
APA
Bedwell, E. V., Emery, F. da S., Clososki, G. C., & Steel, P. G. (2023). Synthesis and vectorial functionalisation of pyrazolo[3,4-c]pyridines. RSC Advances, 13( 49), 34391-34399. doi:10.1039/D3RA07458G
NLM
Bedwell EV, Emery F da S, Clososki GC, Steel PG. Synthesis and vectorial functionalisation of pyrazolo[3,4-c]pyridines [Internet]. RSC Advances. 2023 ; 13( 49): 34391-34399.[citado 2026 abr. 22 ] Available from: https://doi.org/10.1039/D3RA07458G
Vancouver
Bedwell EV, Emery F da S, Clososki GC, Steel PG. Synthesis and vectorial functionalisation of pyrazolo[3,4-c]pyridines [Internet]. RSC Advances. 2023 ; 13( 49): 34391-34399.[citado 2026 abr. 22 ] Available from: https://doi.org/10.1039/D3RA07458G
Artigo de periodico
Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design (2023)
Ferreira, Glaucio Monteiro ; Kronenberger, Thales ; Maltarollo, Vinícius Gonçalves ; Poso, Antti ; Gatti, Fernando de Moura ; Almeida, Vitor Medeiros ; Marana, Sandro Roberto ; Lopes, Carla Duque ; Tezuka, Daiane Yukie; Albuquerque, Sérgio de ; Emery, Flavio da Silva ; Trossini, Gustavo Henrique Goulart
Source: Pharmaceuticals. Unidades: FCF, IQ, FCFRP
Subjects: TRYPANOSOMA CRUZI, ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Glaucio Monteiro et al. Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design. Pharmaceuticals, v. 16 , p. 1-14 art. 428, 2023Tradução . . Disponível em: https://doi.org/10.3390/ph16030428. Acesso em: 22 abr. 2026.
APA
Ferreira, G. M., Kronenberger, T., Maltarollo, V. G., Poso, A., Gatti, F. de M., Almeida, V. M., et al. (2023). Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design. Pharmaceuticals, 16 , 1-14 art. 428. doi:10.3390/ph16030428
NLM
Ferreira GM, Kronenberger T, Maltarollo VG, Poso A, Gatti F de M, Almeida VM, Marana SR, Lopes CD, Tezuka DY, Albuquerque S de, Emery F da S, Trossini GHG. Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design [Internet]. Pharmaceuticals. 2023 ; 16 1-14 art. 428.[citado 2026 abr. 22 ] Available from: https://doi.org/10.3390/ph16030428
Vancouver
Ferreira GM, Kronenberger T, Maltarollo VG, Poso A, Gatti F de M, Almeida VM, Marana SR, Lopes CD, Tezuka DY, Albuquerque S de, Emery F da S, Trossini GHG. Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design [Internet]. Pharmaceuticals. 2023 ; 16 1-14 art. 428.[citado 2026 abr. 22 ] Available from: https://doi.org/10.3390/ph16030428
Artigo de periodico
2-Imidazolidinone benzofurans as unexpected outcome of the Lewis acid mediated Nenitzescu reaction (2022)
Horsten, Tomas; Price, Temitayo Omowumi Alegbejo ; Van Meervelt, Luc; Emery, Flavio da Silva ; Dehaen, Wim
Source: New Journal of Chemistry. Unidade: FCFRP
Subjects: SÍNTESE QUÍMICA, BENZENO, COMPOSTOS CÍCLICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HORSTEN, Tomas et al. 2-Imidazolidinone benzofurans as unexpected outcome of the Lewis acid mediated Nenitzescu reaction. New Journal of Chemistry, v. 46, n. 5, p. 2028-2032, 2022Tradução . . Disponível em: https://doi.org/10.1039/d1nj04965h. Acesso em: 22 abr. 2026.
APA
Horsten, T., Price, T. O. A., Van Meervelt, L., Emery, F. da S., & Dehaen, W. (2022). 2-Imidazolidinone benzofurans as unexpected outcome of the Lewis acid mediated Nenitzescu reaction. New Journal of Chemistry, 46( 5), 2028-2032. doi:10.1039/d1nj04965h
NLM
Horsten T, Price TOA, Van Meervelt L, Emery F da S, Dehaen W. 2-Imidazolidinone benzofurans as unexpected outcome of the Lewis acid mediated Nenitzescu reaction [Internet]. New Journal of Chemistry. 2022 ; 46( 5): 2028-2032.[citado 2026 abr. 22 ] Available from: https://doi.org/10.1039/d1nj04965h
Vancouver
Horsten T, Price TOA, Van Meervelt L, Emery F da S, Dehaen W. 2-Imidazolidinone benzofurans as unexpected outcome of the Lewis acid mediated Nenitzescu reaction [Internet]. New Journal of Chemistry. 2022 ; 46( 5): 2028-2032.[citado 2026 abr. 22 ] Available from: https://doi.org/10.1039/d1nj04965h
Curadoria
Brazilian Symposium on Medicinal Chemistry - BrazMedChem (2022)
Guido, Rafael Victorio Carvalho (cur) ; Emery, Flavio da Silva (cur)
Unidades: IFSC, FCFRP
Subjects: CRISTALOGRAFIA, QUÍMICA MÉDICA, PESQUISA CIENTÍFICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Brazilian Symposium on Medicinal Chemistry - BrazMedChem. . Campinas: Galoá. Disponível em: https://repositorio.usp.br/directbitstream/0f341ece-4aaa-4551-8663-71fe3fa3625c/P22992.pdf. Acesso em: 22 abr. 2026. , 2022
APA
Brazilian Symposium on Medicinal Chemistry - BrazMedChem. (2022). Brazilian Symposium on Medicinal Chemistry - BrazMedChem. Campinas: Galoá. Recuperado de https://repositorio.usp.br/directbitstream/0f341ece-4aaa-4551-8663-71fe3fa3625c/P22992.pdf
NLM
Brazilian Symposium on Medicinal Chemistry - BrazMedChem [Internet]. 2022 ;[citado 2026 abr. 22 ] Available from: https://repositorio.usp.br/directbitstream/0f341ece-4aaa-4551-8663-71fe3fa3625c/P22992.pdf
Vancouver
Brazilian Symposium on Medicinal Chemistry - BrazMedChem [Internet]. 2022 ;[citado 2026 abr. 22 ] Available from: https://repositorio.usp.br/directbitstream/0f341ece-4aaa-4551-8663-71fe3fa3625c/P22992.pdf
Artigo de periodico
Synthesis and structure−activity relationships of imidazopyridine/pyrimidine- and furopyridine‐based anti‐infective agents against Trypanosomiases (2021)
Silva, Daniel G.; Junker, Anna; Melo, Shaiani Maria Gil de ; Fumagalli, Fernando; Gillespie, J. Robert; Molasky, Nora; Buckner, Frederick S.; Matheeussen, An; Caljon, Guy; Maes, Louis; Emery, Flavio da Silva
Source: ChemMedChem. Unidade: FCFRP
Subjects: TRIPANOSSOMICIDAS, ANTI-INFECCIOSOS, COMPOSTOS HETEROCÍCLICOS, DOENÇAS NEGLIGENCIADAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Daniel G. et al. Synthesis and structure−activity relationships of imidazopyridine/pyrimidine- and furopyridine‐based anti‐infective agents against Trypanosomiases. ChemMedChem, v. 16, n. 6, p. 966-975, 2021Tradução . . Disponível em: https://doi.org/10.1002/cmdc.202000616. Acesso em: 22 abr. 2026.
APA
Silva, D. G., Junker, A., Melo, S. M. G. de, Fumagalli, F., Gillespie, J. R., Molasky, N., et al. (2021). Synthesis and structure−activity relationships of imidazopyridine/pyrimidine- and furopyridine‐based anti‐infective agents against Trypanosomiases. ChemMedChem, 16( 6), 966-975. doi:10.1002/cmdc.202000616
NLM
Silva DG, Junker A, Melo SMG de, Fumagalli F, Gillespie JR, Molasky N, Buckner FS, Matheeussen A, Caljon G, Maes L, Emery F da S. Synthesis and structure−activity relationships of imidazopyridine/pyrimidine- and furopyridine‐based anti‐infective agents against Trypanosomiases [Internet]. ChemMedChem. 2021 ; 16( 6): 966-975.[citado 2026 abr. 22 ] Available from: https://doi.org/10.1002/cmdc.202000616
Vancouver
Silva DG, Junker A, Melo SMG de, Fumagalli F, Gillespie JR, Molasky N, Buckner FS, Matheeussen A, Caljon G, Maes L, Emery F da S. Synthesis and structure−activity relationships of imidazopyridine/pyrimidine- and furopyridine‐based anti‐infective agents against Trypanosomiases [Internet]. ChemMedChem. 2021 ; 16( 6): 966-975.[citado 2026 abr. 22 ] Available from: https://doi.org/10.1002/cmdc.202000616
Artigo de periodico
Structural basis for the function and inhibition of dihydroorotate dehydrogenase from Schistosoma mansoni (2021)
Mori, Renan Minin de ; Aleixo, Mariana Araújo Ajalla; Zapata, Luana Carlos Campisano ; Calil, Felipe A.; Emery, Flavio da Silva ; Nonato, Maria Cristina
Source: The FEBS Journal. Unidade: FCFRP
Subjects: SCHISTOSOMA MANSONI, ESQUISTOSSOMOSE, FÁRMACOS, ANTI-HELMÍNTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORI, Renan Minin de et al. Structural basis for the function and inhibition of dihydroorotate dehydrogenase from Schistosoma mansoni. The FEBS Journal, v. 288, n. 3, p. 930-944, 2021Tradução . . Disponível em: https://doi.org/10.1111/febs.15367. Acesso em: 22 abr. 2026.
APA
Mori, R. M. de, Aleixo, M. A. A., Zapata, L. C. C., Calil, F. A., Emery, F. da S., & Nonato, M. C. (2021). Structural basis for the function and inhibition of dihydroorotate dehydrogenase from Schistosoma mansoni. The FEBS Journal, 288( 3), 930-944. doi:10.1111/febs.15367
NLM
Mori RM de, Aleixo MAA, Zapata LCC, Calil FA, Emery F da S, Nonato MC. Structural basis for the function and inhibition of dihydroorotate dehydrogenase from Schistosoma mansoni [Internet]. The FEBS Journal. 2021 ; 288( 3): 930-944.[citado 2026 abr. 22 ] Available from: https://doi.org/10.1111/febs.15367
Vancouver
Mori RM de, Aleixo MAA, Zapata LCC, Calil FA, Emery F da S, Nonato MC. Structural basis for the function and inhibition of dihydroorotate dehydrogenase from Schistosoma mansoni [Internet]. The FEBS Journal. 2021 ; 288( 3): 930-944.[citado 2026 abr. 22 ] Available from: https://doi.org/10.1111/febs.15367
Artigo de periodico
A review of the synthetic strategies toward Dihydropyrrolo [1,2-a] Pyrazinones (2021)
Winant, Pieterjan; Horsten, Tomas; Melo, Shaiani Maria Gil de ; Emery, Flavio da Silva ; Dehaen, Wim
Source: Organics. Unidade: FCFRP
Subjects: PRODUTOS NATURAIS, FÁRMACOS SINTÉTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WINANT, Pieterjan et al. A review of the synthetic strategies toward Dihydropyrrolo [1,2-a] Pyrazinones. Organics, v. 2, n. 2, p. 118-141, 2021Tradução . . Disponível em: https://doi.org/10.3390/org2020011. Acesso em: 22 abr. 2026.
APA
Winant, P., Horsten, T., Melo, S. M. G. de, Emery, F. da S., & Dehaen, W. (2021). A review of the synthetic strategies toward Dihydropyrrolo [1,2-a] Pyrazinones. Organics, 2( 2), 118-141. doi:10.3390/org2020011
NLM
Winant P, Horsten T, Melo SMG de, Emery F da S, Dehaen W. A review of the synthetic strategies toward Dihydropyrrolo [1,2-a] Pyrazinones [Internet]. Organics. 2021 ; 2( 2): 118-141.[citado 2026 abr. 22 ] Available from: https://doi.org/10.3390/org2020011
Vancouver
Winant P, Horsten T, Melo SMG de, Emery F da S, Dehaen W. A review of the synthetic strategies toward Dihydropyrrolo [1,2-a] Pyrazinones [Internet]. Organics. 2021 ; 2( 2): 118-141.[citado 2026 abr. 22 ] Available from: https://doi.org/10.3390/org2020011
Artigo de periodico
PCL-TPGS polymeric nanoparticles for docetaxel delivery to prostate cancer: development, physicochemical and biological characterization (2021)
Raspantini, Giovanni Loureiro ; Luiz, Marcela Tavares ; Abriata, Juliana Palma ; Eloy, Josimar de Oliveira ; Vaidergorn, Miguel Menezes; Emery, Flavio da Silva ; Marchetti, Juliana Maldonado
Source: Colloids and Surfaces A: Physicochemical and Engineering Aspects. Unidade: FCFRP
Subjects: NANOPARTÍCULAS, PRÓSTATA, NEOPLASIAS, NEOPLASIAS UROGENITAIS, QUIMIOTERAPIA, RASTREAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RASPANTINI, Giovanni Loureiro et al. PCL-TPGS polymeric nanoparticles for docetaxel delivery to prostate cancer: development, physicochemical and biological characterization. Colloids and Surfaces A: Physicochemical and Engineering Aspects, v. 627, p. 1-11, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.colsurfa.2021.127144. Acesso em: 22 abr. 2026.
APA
Raspantini, G. L., Luiz, M. T., Abriata, J. P., Eloy, J. de O., Vaidergorn, M. M., Emery, F. da S., & Marchetti, J. M. (2021). PCL-TPGS polymeric nanoparticles for docetaxel delivery to prostate cancer: development, physicochemical and biological characterization. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 627, 1-11. doi:10.1016/j.colsurfa.2021.127144
NLM
Raspantini GL, Luiz MT, Abriata JP, Eloy J de O, Vaidergorn MM, Emery F da S, Marchetti JM. PCL-TPGS polymeric nanoparticles for docetaxel delivery to prostate cancer: development, physicochemical and biological characterization [Internet]. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2021 ; 627 1-11.[citado 2026 abr. 22 ] Available from: https://doi.org/10.1016/j.colsurfa.2021.127144
Vancouver
Raspantini GL, Luiz MT, Abriata JP, Eloy J de O, Vaidergorn MM, Emery F da S, Marchetti JM. PCL-TPGS polymeric nanoparticles for docetaxel delivery to prostate cancer: development, physicochemical and biological characterization [Internet]. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2021 ; 627 1-11.[citado 2026 abr. 22 ] Available from: https://doi.org/10.1016/j.colsurfa.2021.127144

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Grupo de pesquisa

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration